News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 232
- Sources here
- 20
- Companies here
- 10
Search results
Stored financial headlines
Active search
232 matching headlines
Ticker or company: XFORMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Rexford Industrial Realty, Inc. (REXR) Stock forecasts
Argus has raised its target price for Rexford Industrial Realty, Inc. (REXR) to $41.00. The company is a real estate investment trust focused on industrial properties in Southern California infill markets. REXR's current price is $36.74.
REXR
main company
Sharemaestro market context
Price above Trend Line
52 weeks -7.2%
X4 Pharmaceuticals (NASDAQ: XFOR) wins EU nod, posts $16.2M Q2 loss
X4 Pharmaceuticals (NASDAQ: XFOR) reported a Q2 2026 net loss of $16.2 million, a narrowing from $25.7 million in the prior year, despite revenue rising to $8.8 million. The revenue increase was driven by licensing and product sales of XOLREMDI, which recently gained European …
XFOR
main company
Sharemaestro market context
Trend signal active
52 weeks +7.7% · Next-week setup negative 40.0%
FMR LLC and Abigail P. Johnson (OXM) disclose 10% Oxford Industries stake on 13G/A
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a beneficial ownership stake of 10.0% in Oxford Industries, Inc., totaling 1,498,970.72 common shares. FMR LLC holds sole dispositive power over all these shares and sole voting power over 1,498,493 shares, …
OXM
main company
Sharemaestro market context
Price below Trend Line
52 weeks -18.6%
Rexford Industrial Realty, Inc. (NYSE:REXR) Receives Average Recommendation of "Hold" from Analysts
Rexford Industrial Realty, Inc. (NYSE:REXR) has received an average recommendation of "Hold" from fourteen brokerages, with an average 12-month price target of $40.62. The company reported a quarterly loss of $2.26 per share, missing analyst estimates, but revenue slightly exceeded forecasts at $243 million. …
REXR
main company
Sharemaestro market context
Price above Trend Line
52 weeks -7.2%
X4 Pharmaceuticals (XFOR) Reports Q2 Loss, Beats Revenue Estimates
X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $3.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …
XFOR
main company
Sharemaestro market context
Trend signal active
52 weeks +7.7% · Next-week setup negative 40.0%
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
X4 Pharmaceuticals announced inducement awards to new employees consisting of options to purchase 12,000 shares of common stock. These grants were made under the company's 2019 Inducement Equity Incentive Plan, approved by the Compensation Committee, and comply with Nasdaq Listing Rule 5635(c)(4). The options …
XFOR
main company
Sharemaestro market context
Trend signal active
52 weeks +7.7% · Next-week setup negative 40.0%
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
X4 Pharmaceuticals Inc is projected to report a loss of 18 cents per share. This earnings preview, sourced from Reuters via Refinitiv, indicates an upcoming financial update for the company. The full article provides more details on this expectation.
XFOR
main company
Sharemaestro market context
Trend signal active
52 weeks +7.7% · Next-week setup negative 40.0%
OXFORD LANE CAPITAL CORP 6% TERM PREFERRED SER 2029 To Go Ex-Dividend On October 16th, 2026 With 0.125 USD Dividend Per Share
Oxford Lane Capital Corp 6% Term Preferred Ser 2029 (NASDAQ: OXLCM) is scheduled to go ex-dividend on October 16th, 2026. Shareholders will receive a dividend of 0.125 USD per share. This information is relevant for investors tracking dividend income from this preferred stock.
OXLCM
main company
Sharemaestro market context
Trend signal active
28 weeks +3.2% · Next-week setup positive 59.3%
Lazard Asset Management LLC Sells 33,318 Shares of Oxford Industries, Inc. $OXM
Lazard Asset Management LLC significantly reduced its stake in Oxford Industries (NYSE:OXM) by 39.7%, selling 33,318 shares and retaining 50,554 shares valued at $1.95 million. The company reported better-than-expected Q1 EPS of $1.39 but slightly missed revenue estimates. Analysts maintain a cautious "Reduce" rating …
OXM
main company
Sharemaestro market context
Price below Trend Line
52 weeks -18.6%
Oxford Industries, Inc. Revenue Breakdown – NYSE:OXM
Oxford Industries, Inc. (NYSE: OXM) generated total revenue of $1.48 billion USD last year. The Tommy Bahama segment was the top performer, contributing $828.54 million USD, though this was a decrease from the previous year. The majority of the company's revenue, $1.44 billion USD, …
OXM
main company
Sharemaestro market context
Price below Trend Line
52 weeks -18.6%
X4 Pharmaceuticals issues inducement stock options for 12,000 shares at $3.98 each
X4 Pharmaceuticals has issued inducement stock options for 12,000 shares to new employees under its 2019 Inducement Equity Incentive Plan. These options have a 10-year term, an exercise price of $3.98 per share (based on the July 31 close), and a four-year vesting schedule, …
XFOR
main company
Sharemaestro market context
Trend signal active
52 weeks +7.7% · Next-week setup negative 40.0%
Oxford Industries, Inc. Actuals & Estimates (NYSE:OXM)
This article provides an overview of Oxford Industries, Inc. (NYSE: OXM), including its current stock price, market capitalization, volatility, and historical performance. It also details financial actuals and analyst estimates for earnings and revenue, dividend information, and upcoming earnings report dates. The article compiles …
OXM
main company
Sharemaestro market context
Price below Trend Line
52 weeks -18.6%